Search

9 Aug 2013: Dr Karen Ersche, from the Behavioural and Clinical Neuroscience Institute at the University of Cambridge, said: “Our findings challenge the widely held assumptions that cocaine use leads to weight loss through ... This work was funded by the Medical

10 Nov 2005: Search. Search. Academic to give prestigious neuroscience lecture. News. Academic to give prestigious neuroscience lecture.. ... In addition to his role as Head of the Department, Professor Robbins is the Director of the Cambridge MRC-Wellcome Trust

13 Oct 2014: Our Wellcome Trust-MRC Cambridge Stem Cell Institute is a world-leading research centre, and stem cell research has long been a strategic priority for our University. ... Funds are now being raised for a new building for our expanding Institute,

23 May 2011: The team, led by Claire Gillan and Trevor Robbins at the University of Cambridge MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute and Sanne de Wit at the University of Amsterdam,

7 Dec 2010: Additional support was provided by the Medical Research Council and the Wellcome Trust through their funding of the University of Cambridge’s Behavioural and Clinical Neuroscience Institute.

17 Mar 2011: The fact that drugs can produce mind-altering effects through chemical activity has been known for centuries,” explained Professor Robbins, who is Director of the Behavioural and Clinical Neuroscience Institute and

12 May 2010: 10 | Issue 12 | Summer 2010. BUILDING THE FUTURE. Making the most of ideas: Institute for Manufacturing. ... Professor Mike Gregory, Head of the IfM, outlines the scope of research activity atthe Institute:.

20 Jul 2006: The Gurdon Institute will do everything possible to support her in these activities.". ... Dr Brand is the Director of Research in Developmental Neurobiology at the Wellcome Trust/Cancer Research UK Gurdon Institute and the Department of Physiology,

4 Jan 2011: Professor Barry Everitt and Dr Jonathan Lee of the MRC-Wellcome Behaviour and Clinical Neuroscience Institute have shown that they can selectively impair memories associated with drug addiction and PTSD by

2 Mar 2007: brain. Dr Jeff Dalley and colleagues, at the Behavioural and Clinical Neuroscience Institute, may have resolved this debate by demonstrating that changes in a neurotransmitter receptor in a particular part of